Last update:
Weight management news
Encouraging trial results for AstraZeneca's new weight-loss pill
A new pill developed by the British pharmaceutical firm AstraZeneca appears to help people lose a similar amount of weight as other oral GLP-1 drugs, trial results showed Monday.
3 hours ago
0
0
New GLP-1 oral pill lowers blood sugar and reduces bodyweight, clinical trial finds
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
16 hours ago
0
8
Study shows US tobacco firms used cigarette-selling tactics to globally market ultra-processed foods
A new study from the University of Kansas details how U.S. tobacco corporations expanded into global food markets from the mid-1980s to the mid-2000s, using strategies honed through cigarette sales to market ultra-processed ...
18 hours ago
0
7
No, regaining weight after losing it won't permanently damage your metabolism: New research
When it comes to losing weight, the fear of "ruining your metabolism" is widespread. Indeed, many people who have lost weight and then put it back on feel that every failed attempt leaves them worse off than before, with ...
14 hours ago
0
2
Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes
A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers. The research found that GLP-1 receptor agonists ...
Jun 7, 2026
0
8
GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease
Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious ...
Jun 6, 2026
0
8
Fasting after 60 changes more than waistlines, exposing a trade-off many dieters never see coming
Most folks know intermittent fasting helps with weight loss, usually by limiting your daily eating window or cutting calories a couple of times a week. But does your age change how well this works for you—and might there ...
Experts highlight limits of evidence from ultraprocessed food trials
A group of eating behavior and metabolism experts from across Europe have published a Perspective article in the journal Science examining the limitations of current evidence on ultraprocessed foods (UPFs).
Jun 5, 2026
0
7
'Dad bods' may influence childhood obesity risks, review suggests
As obesity rates rise across the U.S., new research from Joe C. Wen School of Population & Public Health at the University of California, Irvine scientists draws attention to an often-overlooked factor in children's long-term ...
Jun 5, 2026
1
4
It may not just be what's in ultra-processed foods, but how they're made
Concerns about the health effects of ultra-processed foods are growing, as studies increasingly link them to conditions such as heart disease, diabetes, and even early death. But scientists are still debating what's driving ...
Jun 4, 2026
0
7
Poll finds broad support for stricter regulations on ultra-processed foods
Top food researchers have teamed up on a special issue of the American Journal of Public Health to push policymakers for stricter action on ultra-processed foods (UPFs).
Jun 4, 2026
1
2
How big tobacco helped shape the design of ultra-processed foods
A new UC San Francisco study reveals how Philip Morris Companies Inc. used cigarette research, flavor engineering, and behavioral science to turn Lunchables into one of America's most successful ultra-processed foods for ...
Jun 3, 2026
0
8
Empty stomach, vivid cravings: Hunger boosts imagined smell and flavor of food
People are often told not to go to the supermarket on an empty stomach. Findings from a new University of Otago—Ōtākou Whakaihu Waka study potentially explain this theory, revealing that the way we think about food changes ...
Jun 3, 2026
0
4
Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said. The 31-year-old compliance consultant ...
Jun 3, 2026
0
4
Why drinking alcohol may make you reach for chips and pizza
Drinking alcohol may lead people to overconsume savory ultra-processed foods, according to new research from the University of Sydney's Charles Perkins Centre, with researchers suggesting this may contribute to excess energy ...
Jun 3, 2026
0
4
Researchers first to estimate pediatric obesity prevalence using new definition
Researchers at Pennington Biomedical Research Center have published the first study to estimate the prevalence of pediatric obesity among U.S. children and adolescents using the new Lancet Commission on Clinical Obesity definitions ...
Jun 3, 2026
0
4
Existing drug enhances muscle repair during GLP-1 weight-loss treatment in mice
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn't return quickly, and ...
Jun 2, 2026
0
9
GLP-1 use linked to lower breast cancer incidence in large cohort study
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, ...
Jun 2, 2026
0
10
Could a gut microbe help reduce weight regain after dieting? New study suggests it might
Losing weight is hard. Keeping it off is often even harder.
Jun 2, 2026
0
5
GLP-1 agonists linked to significantly lower long-term risk of knee replacement
GLP-1 receptor agonist drugs, used for the treatment of diabetes—and more recently, weight loss—are associated with a significantly lower long-term risk of knee replacement surgery as a result of osteoarthritis, finds an ...
Jun 2, 2026
0
4
GLP‑1 drugs like Ozempic show promise for more than weight loss, but what's science vs. hype?
You've probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes.
Jun 2, 2026
0
3
Why BMI may be missing obesity in millions of Americans with health risks
Could the way doctors traditionally measure obesity allow a subset of people with obesity-related health risks to slip through the cracks? Medical experts have typically calculated obesity using body mass index (BMI), a calculation ...
Jun 1, 2026
0
5
Weight loss surgery boosts household independence for 20 years, data show
People who undergo bariatric surgery and see substantial weight loss are better able to cope with household tasks such as cleaning, laundry, and grocery shopping. The improvements are also sustained over a long time, according ...
Jun 1, 2026
0
2
How digital platforms and policy shifts reshape GLP-1 affordability
A News and Perspectives report on emerging pharmaceutical access models in the United States has been published in the Journal of Medical Internet Research. In "Affordable GLP-1? When Digital Platforms Meet Policy Reform", ...
Jun 1, 2026
0
4
Weight loss drugs risk widening health inequalities, warn researchers
Drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are transforming obesity treatment, but without affordable, healthy food and appropriate support, they could widen health inequalities in the UK, according ...
Jun 1, 2026
0
3
